COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY. RMSR. 2025;3(6):94-100. Accessed August 6, 2025. https://medscireview.net/index.php/Journal/article/view/1284